SG11202006388SA - Multivalent pneumococcal polysaccharide-protein conjugate composition - Google Patents
Multivalent pneumococcal polysaccharide-protein conjugate compositionInfo
- Publication number
- SG11202006388SA SG11202006388SA SG11202006388SA SG11202006388SA SG11202006388SA SG 11202006388S A SG11202006388S A SG 11202006388SA SG 11202006388S A SG11202006388S A SG 11202006388SA SG 11202006388S A SG11202006388S A SG 11202006388SA SG 11202006388S A SG11202006388S A SG 11202006388SA
- Authority
- SG
- Singapore
- Prior art keywords
- protein conjugate
- conjugate composition
- pneumococcal polysaccharide
- multivalent pneumococcal
- multivalent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862626509P | 2018-02-05 | 2018-02-05 | |
| KR20180045246 | 2018-04-18 | ||
| PCT/US2019/016511 WO2019152925A1 (en) | 2018-02-05 | 2019-02-04 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202006388SA true SG11202006388SA (en) | 2020-07-29 |
Family
ID=67478943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202006388SA SG11202006388SA (en) | 2018-02-05 | 2019-02-04 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11123417B2 (en) |
| EP (1) | EP3749357A4 (en) |
| JP (4) | JP6950099B2 (en) |
| KR (2) | KR20230008923A (en) |
| CN (1) | CN111757753A (en) |
| AR (1) | AR127517A2 (en) |
| AU (1) | AU2019215216A1 (en) |
| BR (1) | BR112020015696A2 (en) |
| CA (1) | CA3089007A1 (en) |
| IL (2) | IL304977A (en) |
| MX (1) | MX2020008198A (en) |
| PH (1) | PH12020551149A1 (en) |
| SG (1) | SG11202006388SA (en) |
| TW (1) | TWI826420B (en) |
| WO (1) | WO2019152925A1 (en) |
| ZA (1) | ZA202202600B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11160855B2 (en) * | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| MX2019001342A (en) | 2016-08-05 | 2019-07-04 | Sanofi Pasteur Inc | Multivalent pneumococcal polysaccharide-protein conjugate composition. |
| EP3493840B1 (en) | 2016-08-05 | 2022-08-24 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| EP3720483A2 (en) | 2017-12-06 | 2020-10-14 | Merck Sharp&Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| IL304977A (en) | 2018-02-05 | 2023-10-01 | Sanofi Pasteur Inc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| EP3749358A4 (en) | 2018-02-05 | 2022-04-20 | Sanofi Pasteur, Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| BR112020021296A2 (en) | 2018-04-18 | 2021-01-26 | Sk Bioscience Co., Ltd. | capsular polysaccharide of streptococcus pneumoniae and its immunogenic conjugate |
| CR20210333A (en) | 2018-12-19 | 2021-08-18 | Merck Sharp & Dohme | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| EP4003410A1 (en) | 2019-07-31 | 2022-06-01 | Sanofi Pasteur, Inc. | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239643A (en) | 1990-09-17 | 1996-05-28 | North American Vaccine Inc | Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group. |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| US5866132A (en) | 1995-06-07 | 1999-02-02 | Alberta Research Council | Immunogenic oligosaccharide compositions |
| AU725279B2 (en) | 1995-06-07 | 2000-10-12 | Alberta Research Council Inc. | Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them |
| US5695768A (en) | 1995-06-07 | 1997-12-09 | Alberta Research Council | Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides |
| CA2153730A1 (en) | 1995-07-12 | 1997-01-13 | Andrew J. Malcolm | Immunostimulating activity of streptococcus pneumoniae serotype 8 oligosaccharides |
| CA2153733A1 (en) | 1995-07-12 | 1997-01-13 | Andrew J. Malcolm | Immunogenic oligosaccharide compositions |
| FR2763244B1 (en) | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | MULTIVALENT VACCINE COMPOSITION WITH MIXED CARRIER |
| CA2365296A1 (en) | 1999-03-19 | 2000-09-28 | Pierre Michel Desmons | Vaccine |
| FR2806304B1 (en) * | 2000-03-17 | 2002-05-10 | Aventis Pasteur | POLYSACCHARIDIC CONJUGATES OF PNEUMOCOCCUS FOR VACCINE USE AGAINST TETANUS AND DIPHTHERIA |
| GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| MXPA03000198A (en) | 2000-06-29 | 2004-09-13 | Glaxosmithkline Biolog Sa | Vaccine composition. |
| AU2007200116A1 (en) | 2001-04-03 | 2007-02-01 | Glaxosmithkline Biologicals S.A. | Vaccine composition |
| GB0130215D0 (en) | 2001-12-18 | 2002-02-06 | Glaxosmithkline Biolog Sa | Vaccine |
| TWI346555B (en) | 2002-04-01 | 2011-08-11 | Glaxosmithkline Biolog Sa | Vaccine composition |
| TWI341210B (en) | 2002-04-01 | 2011-05-01 | Glaxosmithkline Biolog Sa | Vaccine kit |
| ES2295836T3 (en) | 2003-03-13 | 2008-04-16 | Glaxosmithkline Biologicals S.A. | BACTERIAL CITOLISINE PURIFICATION PROCEDURE. |
| US7320874B2 (en) | 2003-07-08 | 2008-01-22 | Aventis Pasteur Sa | Assaying the teichoic acids of gram+ bacteria |
| GB0421083D0 (en) | 2004-09-22 | 2004-10-27 | Glaxosmithkline Biolog Sa | Purification process |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| CN104815327A (en) | 2005-04-08 | 2015-08-05 | 惠氏有限责任公司 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| CA2808919C (en) | 2005-12-22 | 2016-04-19 | Glaxosmithkline Biologicals S.A. | Streptococcus pneumoniae capsular saccharide vaccine |
| US8808707B1 (en) | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
| DK2167121T3 (en) | 2007-06-26 | 2015-11-23 | Glaxosmithkline Biolog Sa | A vaccine comprising Streptococcus pneumoniae kapselpolysaccharidkonjugater |
| KR101450958B1 (en) | 2009-04-30 | 2014-10-15 | 콜레이 파마시티컬 그룹, 인코포레이티드 | Pneumococcal vaccine and uses therof |
| TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| CN101785857B (en) | 2010-03-05 | 2012-09-26 | 成都安特金生物技术有限公司 | Novel pneumococcal conjugate vaccine and preparation method thereof |
| GB201003920D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
| HUE048398T2 (en) | 2010-06-04 | 2020-07-28 | Wyeth Llc | Vaccine formulations |
| CN102068690A (en) | 2010-12-31 | 2011-05-25 | 北京民海生物科技有限公司 | Polyvalent pneumococcal capsular polysaccharide conjugate vaccine and preparation method thereof |
| KR102057217B1 (en) | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US9517274B2 (en) | 2012-08-16 | 2016-12-13 | Pfizer Inc. | Glycoconjugation processes and compositions |
| CN103623401A (en) * | 2012-08-23 | 2014-03-12 | 北京科兴中维生物技术有限公司 | Multivalent pneumococcus capsular polysaccharide-protein conjugated composition and preparation method thereof |
| CN103656632B (en) | 2012-09-24 | 2016-01-13 | 北京科兴中维生物技术有限公司 | Multivalent pneumococcal capsular polysaccharide composition, its preparation method and application |
| CN103656631B (en) * | 2012-09-24 | 2015-08-19 | 北京科兴中维生物技术有限公司 | multivalent pneumococcal capsular polysaccharide-protein conjugate composition and preparation method thereof |
| KR20140075201A (en) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| KR20140075196A (en) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| ITMI20130142A1 (en) | 2013-01-31 | 2014-08-01 | Biosynth Srl | GLYCOCOUGUGAR VACCINES INCLUDING BASIC UNITS OF AN EXPRIMENT MOLECULAR CONSTRUCTED MULTIPLE EPITHOPES INCORPORATED |
| MX371453B (en) | 2014-01-21 | 2020-01-29 | Pfizer | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof. |
| CN105934251A (en) | 2014-01-21 | 2016-09-07 | 辉瑞大药厂 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
| AU2015208821B2 (en) | 2014-01-21 | 2017-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| CN104069504B (en) | 2014-05-11 | 2019-09-24 | 江苏康泰生物医学技术有限公司 | A method of enhancing polysaccharide protein conjugate immunogenicity |
| CN107029225B (en) | 2014-07-25 | 2020-08-11 | 武汉博沃生物科技有限公司 | Conjugate vaccine and preparation method thereof |
| FI3244917T3 (en) | 2015-01-15 | 2023-05-25 | Pfizer | Immunogenic compositions for use in pneumococcal vaccines |
| LT3313436T (en) | 2015-06-23 | 2021-06-10 | Biological E Limited | Multivalent pneumococcal conjugate vaccine |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| CA3005524C (en) | 2015-11-20 | 2023-10-10 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
| EP3436061A4 (en) | 2016-03-31 | 2019-12-04 | Liffey Biotech Limited | Saccharide-polypeptide conjugate compositions and methods of use thereof |
| CN106140046B (en) | 2016-07-06 | 2019-02-22 | 江南大学 | Array induction field fluid reaction system and its application |
| EP3493840B1 (en) | 2016-08-05 | 2022-08-24 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| MX2019001342A (en) | 2016-08-05 | 2019-07-04 | Sanofi Pasteur Inc | Multivalent pneumococcal polysaccharide-protein conjugate composition. |
| MX2019002552A (en) | 2016-09-06 | 2019-07-01 | Lg Chemical Ltd | Composition comprising multivalent capsular polysaccharide-transp ort protein and use thereof. |
| EP3518965A1 (en) * | 2016-09-30 | 2019-08-07 | Biological E Limited | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
| JP2020533299A (en) | 2017-09-07 | 2020-11-19 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | Formulation method of Streptococcus pneumoniae polysaccharide for conjugation to carrier protein |
| AU2018328035B2 (en) | 2017-09-07 | 2024-03-07 | Chitrananda Abeygunawardana | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| KR20200051005A (en) | 2017-09-07 | 2020-05-12 | 머크 샤프 앤드 돔 코포레이션 | Pneumococcal polysaccharide and its use in immunogenic polysaccharide-carrier protein conjugates |
| CA3074708A1 (en) | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| WO2019070994A1 (en) | 2017-10-04 | 2019-04-11 | Liffey Biotech Limited | Saccharide-polypeptide conjugate compositions and methods of use thereof |
| EP3720483A2 (en) | 2017-12-06 | 2020-10-14 | Merck Sharp&Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| IL304977A (en) | 2018-02-05 | 2023-10-01 | Sanofi Pasteur Inc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| EP3749358A4 (en) | 2018-02-05 | 2022-04-20 | Sanofi Pasteur, Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| BR112020021296A2 (en) | 2018-04-18 | 2021-01-26 | Sk Bioscience Co., Ltd. | capsular polysaccharide of streptococcus pneumoniae and its immunogenic conjugate |
| EP4003410A1 (en) | 2019-07-31 | 2022-06-01 | Sanofi Pasteur, Inc. | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same |
-
2019
- 2019-02-04 IL IL304977A patent/IL304977A/en unknown
- 2019-02-04 JP JP2020542271A patent/JP6950099B2/en active Active
- 2019-02-04 SG SG11202006388SA patent/SG11202006388SA/en unknown
- 2019-02-04 EP EP19748037.9A patent/EP3749357A4/en active Pending
- 2019-02-04 WO PCT/US2019/016511 patent/WO2019152925A1/en unknown
- 2019-02-04 US US16/966,584 patent/US11123417B2/en active Active
- 2019-02-04 BR BR112020015696-5A patent/BR112020015696A2/en unknown
- 2019-02-04 CA CA3089007A patent/CA3089007A1/en active Pending
- 2019-02-04 KR KR1020237000531A patent/KR20230008923A/en active Application Filing
- 2019-02-04 KR KR1020207025716A patent/KR102486891B1/en active IP Right Grant
- 2019-02-04 MX MX2020008198A patent/MX2020008198A/en unknown
- 2019-02-04 AU AU2019215216A patent/AU2019215216A1/en active Pending
- 2019-02-04 CN CN201980011404.1A patent/CN111757753A/en active Pending
- 2019-02-04 IL IL276230A patent/IL276230B2/en unknown
- 2019-02-11 TW TW108104495A patent/TWI826420B/en active
-
2020
- 2020-07-29 PH PH12020551149A patent/PH12020551149A1/en unknown
-
2021
- 2021-09-10 US US17/471,825 patent/US11911452B2/en active Active
- 2021-09-21 JP JP2021153537A patent/JP7030235B2/en active Active
-
2022
- 2022-02-21 JP JP2022024522A patent/JP7318034B2/en active Active
- 2022-03-03 ZA ZA2022/02600A patent/ZA202202600B/en unknown
- 2022-10-31 AR ARP220102970A patent/AR127517A2/en unknown
-
2023
- 2023-07-19 JP JP2023117178A patent/JP2023134727A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20200120926A (en) | 2020-10-22 |
| EP3749357A1 (en) | 2020-12-16 |
| US20210077608A1 (en) | 2021-03-18 |
| WO2019152925A1 (en) | 2019-08-08 |
| BR112020015696A2 (en) | 2020-12-08 |
| TWI826420B (en) | 2023-12-21 |
| JP7318034B2 (en) | 2023-07-31 |
| EP3749357A4 (en) | 2022-04-20 |
| US11911452B2 (en) | 2024-02-27 |
| CA3089007A1 (en) | 2019-08-08 |
| KR20230008923A (en) | 2023-01-16 |
| ZA202202600B (en) | 2023-10-25 |
| JP2022068303A (en) | 2022-05-09 |
| JP2022000449A (en) | 2022-01-04 |
| JP2021511367A (en) | 2021-05-06 |
| AU2019215216A1 (en) | 2020-07-23 |
| MX2020008198A (en) | 2020-09-22 |
| JP6950099B2 (en) | 2021-10-13 |
| WO2019152925A8 (en) | 2020-07-16 |
| IL304977A (en) | 2023-10-01 |
| IL276230A (en) | 2020-09-30 |
| KR102486891B1 (en) | 2023-01-10 |
| US20210401963A1 (en) | 2021-12-30 |
| TW201934140A (en) | 2019-09-01 |
| JP2023134727A (en) | 2023-09-27 |
| PH12020551149A1 (en) | 2021-05-31 |
| IL276230B2 (en) | 2024-01-01 |
| CN111757753A (en) | 2020-10-09 |
| IL276230B1 (en) | 2023-09-01 |
| JP7030235B2 (en) | 2022-03-04 |
| US11123417B2 (en) | 2021-09-21 |
| AR127517A2 (en) | 2024-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276229A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| ZA202202600B (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| IL264552A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| IL297575B1 (en) | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates | |
| IL264553A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| ZA201807203B (en) | Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | |
| IL290182A (en) | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same | |
| EP3668541A4 (en) | Pneumococcal conjugate vaccine formulations | |
| ZA201708713B (en) | Multivalent pneumococcal conjugate vaccine | |
| EP3576784A4 (en) | Methods for making polysaccharide-protein conjugates | |
| EP3585803A4 (en) | Pneumococcal conjugate vaccine formulations | |
| EP2932979A4 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| IL281204A (en) | Multivalent pneumococcal vaccines | |
| PL2932980T3 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| IL284349A (en) | Multivalent pneumococcal polysaccharide-protein conjugate vaccine | |
| ZA201708325B (en) | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof | |
| ZA201901969B (en) | A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof | |
| SG11201911757WA (en) | Novel multivalent polysaccharide - protein conjugate vaccine composition and formulation thereof | |
| IL279855A (en) | Improvements in immunogenic conjugates | |
| ZA202103644B (en) | Multivalent glycoconjugates immunogenic compositions | |
| AU2013360597B2 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition |